ATLANTA, Dec. 10, 2017 /PRNewswire-USNewswire/ — For people with certain types of aggressive, refractory blood cancers, treatment options are woefully limited. But three studies being presented today at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in…